Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDM-Induced Allergic Rhinitis”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableStudy completedNCT03127436
What this trial is testing

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Who this might be right for
Perennial Allergic Rhinitis
University Hospital of Cologne 32
Not applicableStudy completedNCT04004351
What this trial is testing

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma

Who this might be right for
Allergy
Stallergenes Greer 1,531
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Testing effectiveness (Phase 2)Study completedNCT03094845
What this trial is testing

Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

Who this might be right for
House Dust Mite Allergy
ASIT Biotech S.A. 36
Large-scale testing (Phase 3)Study completedNCT01603056
What this trial is testing

Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis

Who this might be right for
Allergic Rhinitis
ALK-Abelló A/S 617
Large-scale testing (Phase 3)UnknownNCT05400811
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Who this might be right for
House Dust Mite AllergyPerennial Allergic RhinitisAllergic Rhinoconjunctivitis+1 more
Inmunotek S.L. 400
Large-scale testing (Phase 3)Study completedNCT02596321
What this trial is testing

A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma

Who this might be right for
AllergyAsthmaRhinitis
Abbott 112
Testing effectiveness (Phase 2)Study completedNCT01644617
What this trial is testing

A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)

Who this might be right for
Rhinitis, Allergic, PerennialRhinitis, Allergic, Nonseasonal
ALK-Abelló A/S 124
Early research (Phase 1)Study completedNCT07436208
What this trial is testing

Serum sST2/ miR-223 as a Dual Biomarker for Disease Activity & Clinical Efficacy of SLIT in HDM-Induced Allergic Rhinitis

Who this might be right for
HDM-Induced Allergic Rhinitis
Zagazig University 54